vs
COMMUNITY HEALTH SYSTEMS INC（CYH）与Leidos（LDOS）财务数据对比。点击上方公司名可切换其他公司
Leidos的季度营收约是COMMUNITY HEALTH SYSTEMS INC的1.4倍（$4.2B vs $3.1B），Leidos净利率更高（7.8% vs 3.5%，领先4.2%），Leidos同比增速更快（-3.5% vs -4.8%），Leidos自由现金流更多（$452.0M vs $172.0M），过去两年Leidos的营收复合增速更高（3.1% vs -0.5%）
社区卫生系统公司总部位于美国田纳西州富兰克林，是财富500强企业。按急症护理机构数量计算，该公司曾是美国最大的综合医院医疗服务提供商。2014年它旗下有约200家医院，到2021年机构数量缩减至约85家。
Leidos Holdings, Inc.是总部位于美国弗吉尼亚州雷斯顿的企业，业务覆盖国防、航空、信息技术、生物医学研究领域，提供科研、工程、系统集成及技术服务。其前身为科学应用国际公司（SAIC），2016年8月与洛克希德·马丁旗下IT业务板块合并，成为国防行业规模最大的IT服务提供商。
CYH vs LDOS — 直观对比
营收规模更大
LDOS
是对方的1.4倍
$3.1B
营收增速更快
LDOS
高出1.3%
-4.8%
净利率更高
LDOS
高出4.2%
3.5%
自由现金流更多
LDOS
多$280.0M
$172.0M
两年增速更快
LDOS
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.1B | $4.2B |
| 净利润 | $110.0M | $327.0M |
| 毛利率 | 85.6% | 17.4% |
| 营业利润率 | 14.5% | 11.3% |
| 净利率 | 3.5% | 7.8% |
| 营收同比 | -4.8% | -3.5% |
| 净利润同比 | 254.9% | 15.1% |
| 每股收益（稀释后） | $0.82 | $2.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CYHLDOS
| Q1 26 | — | $4.2B | ||
| Q4 25 | $3.1B | $4.4B | ||
| Q3 25 | $3.1B | $4.2B | ||
| Q2 25 | $3.1B | $4.2B | ||
| Q1 25 | $3.2B | $4.3B | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $3.1B | $4.2B | ||
| Q2 24 | $3.1B | $4.1B |
净利润CYHLDOS
| Q1 26 | — | $327.0M | ||
| Q4 25 | $110.0M | $367.0M | ||
| Q3 25 | $130.0M | $391.0M | ||
| Q2 25 | $282.0M | $363.0M | ||
| Q1 25 | $-13.0M | $284.0M | ||
| Q4 24 | $-71.0M | — | ||
| Q3 24 | $-391.0M | $364.0M | ||
| Q2 24 | $-13.0M | $322.0M |
毛利率CYHLDOS
| Q1 26 | — | 17.4% | ||
| Q4 25 | 85.6% | 18.0% | ||
| Q3 25 | 85.1% | 18.0% | ||
| Q2 25 | 85.0% | 17.5% | ||
| Q1 25 | 84.5% | 15.6% | ||
| Q4 24 | 84.5% | — | ||
| Q3 24 | 84.8% | 17.8% | ||
| Q2 24 | 84.6% | 16.6% |
营业利润率CYHLDOS
| Q1 26 | — | 11.3% | ||
| Q4 25 | 14.5% | 12.0% | ||
| Q3 25 | 7.9% | 13.5% | ||
| Q2 25 | 16.3% | 12.5% | ||
| Q1 25 | 9.0% | 9.7% | ||
| Q4 24 | 8.5% | — | ||
| Q3 24 | -6.6% | 12.4% | ||
| Q2 24 | 7.6% | 11.6% |
净利率CYHLDOS
| Q1 26 | — | 7.8% | ||
| Q4 25 | 3.5% | 8.2% | ||
| Q3 25 | 4.2% | 9.2% | ||
| Q2 25 | 9.0% | 8.6% | ||
| Q1 25 | -0.4% | 6.5% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -12.7% | 8.7% | ||
| Q2 24 | -0.4% | 7.8% |
每股收益（稀释后）CYHLDOS
| Q1 26 | — | $2.54 | ||
| Q4 25 | $0.82 | $2.82 | ||
| Q3 25 | $0.96 | $3.01 | ||
| Q2 25 | $2.09 | $2.77 | ||
| Q1 25 | $-0.10 | $2.10 | ||
| Q4 24 | $-0.53 | — | ||
| Q3 24 | $-2.95 | $2.68 | ||
| Q2 24 | $-0.10 | $2.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $260.0M | $1.1B |
| 总债务越低越好 | $10.4B | $4.6B |
| 股东权益账面价值 | $-1.4B | $4.9B |
| 总资产 | $13.2B | $13.5B |
| 负债/权益比越低杠杆越低 | — | 0.94× |
8季度趋势，按日历期对齐
现金及短期投资CYHLDOS
| Q1 26 | — | $1.1B | ||
| Q4 25 | $260.0M | $974.0M | ||
| Q3 25 | $123.0M | $930.0M | ||
| Q2 25 | $456.0M | $842.0M | ||
| Q1 25 | $431.0M | $943.0M | ||
| Q4 24 | $37.0M | — | ||
| Q3 24 | $33.0M | $1.2B | ||
| Q2 24 | $39.0M | $823.0M |
总债务CYHLDOS
| Q1 26 | — | $4.6B | ||
| Q4 25 | $10.4B | $4.6B | ||
| Q3 25 | — | $5.0B | ||
| Q2 25 | — | $5.0B | ||
| Q1 25 | — | $4.1B | ||
| Q4 24 | $11.5B | — | ||
| Q3 24 | — | $4.1B | ||
| Q2 24 | — | $4.1B |
股东权益CYHLDOS
| Q1 26 | — | $4.9B | ||
| Q4 25 | $-1.4B | $4.9B | ||
| Q3 25 | $-1.5B | $4.7B | ||
| Q2 25 | $-1.6B | $4.3B | ||
| Q1 25 | $-1.9B | $4.4B | ||
| Q4 24 | $-1.9B | — | ||
| Q3 24 | $-1.8B | $4.6B | ||
| Q2 24 | $-1.4B | $4.5B |
总资产CYHLDOS
| Q1 26 | — | $13.5B | ||
| Q4 25 | $13.2B | $13.5B | ||
| Q3 25 | $13.2B | $13.5B | ||
| Q2 25 | $13.6B | $13.2B | ||
| Q1 25 | $13.9B | $13.1B | ||
| Q4 24 | $14.1B | — | ||
| Q3 24 | $13.9B | $13.3B | ||
| Q2 24 | $14.4B | $12.9B |
负债/权益比CYHLDOS
| Q1 26 | — | 0.94× | ||
| Q4 25 | — | 0.94× | ||
| Q3 25 | — | 1.07× | ||
| Q2 25 | — | 1.18× | ||
| Q1 25 | — | 0.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.88× | ||
| Q2 24 | — | 0.92× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.0M | $495.0M |
| 自由现金流经营现金流 - 资本支出 | $172.0M | $452.0M |
| 自由现金流率自由现金流/营收 | 5.5% | 10.8% |
| 资本支出强度资本支出/营收 | 3.0% | 1.0% |
| 现金转化率经营现金流/净利润 | 2.42× | 1.51× |
| 过去12个月自由现金流最近4个季度 | $208.0M | — |
8季度趋势，按日历期对齐
经营现金流CYHLDOS
| Q1 26 | — | $495.0M | ||
| Q4 25 | $266.0M | — | ||
| Q3 25 | $69.0M | $711.0M | ||
| Q2 25 | $88.0M | $58.0M | ||
| Q1 25 | $120.0M | $299.0M | ||
| Q4 24 | $216.0M | — | ||
| Q3 24 | $67.0M | $656.0M | ||
| Q2 24 | $101.0M | $374.0M |
自由现金流CYHLDOS
| Q1 26 | — | $452.0M | ||
| Q4 25 | $172.0M | — | ||
| Q3 25 | $4.0M | $680.0M | ||
| Q2 25 | $-3.0M | $36.0M | ||
| Q1 25 | $35.0M | $213.0M | ||
| Q4 24 | $107.0M | — | ||
| Q3 24 | $-3.0M | $633.0M | ||
| Q2 24 | $13.0M | $351.0M |
自由现金流率CYHLDOS
| Q1 26 | — | 10.8% | ||
| Q4 25 | 5.5% | — | ||
| Q3 25 | 0.1% | 16.1% | ||
| Q2 25 | -0.1% | 0.9% | ||
| Q1 25 | 1.1% | 4.9% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | -0.1% | 15.2% | ||
| Q2 24 | 0.4% | 8.5% |
资本支出强度CYHLDOS
| Q1 26 | — | 1.0% | ||
| Q4 25 | 3.0% | — | ||
| Q3 25 | 2.1% | 0.7% | ||
| Q2 25 | 2.9% | 0.5% | ||
| Q1 25 | 2.7% | 2.0% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 2.3% | 0.6% | ||
| Q2 24 | 2.8% | 0.6% |
现金转化率CYHLDOS
| Q1 26 | — | 1.51× | ||
| Q4 25 | 2.42× | — | ||
| Q3 25 | 0.53× | 1.82× | ||
| Q2 25 | 0.31× | 0.16× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.80× | ||
| Q2 24 | — | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CYH
| Managed Care And Other Third Party Payors | $1.5B | 49% |
| Medicare Managed Care | $570.0M | 18% |
| Medicare | $512.0M | 16% |
| Medicaid | $464.0M | 15% |
| Self Pay Revenue | $34.0M | 1% |
LDOS
| US Do D And US Intelligence Community | $1.4B | 32% |
| Cost Reimbursement And Fixed Price Incentive Fee | $1.0B | 24% |
| Commercial And International Segment | $609.0M | 15% |
| Defense Systems Segment | $546.0M | 13% |
| Other | $358.0M | 9% |
| Time And Materials And Fixed Price Level Of Effort | $295.0M | 7% |
| Commercial And Non US Customers | $38.0M | 1% |
